Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different cancers. R-ketorolac, their lead candidate, is a first-in-class Rac1 inhibitor that shows both clinical and non-clinical evidence of efficacy in ovarian cancer.

Pharmaceutical

Revere Pharmaceuticals

Robert Silverman

Nabil Uddin

Erik Goka

Jedd Levine

Revere Pharmaceuticals' Leadership Team includes Jedd Levine and 2 others.

Leadership Team

About

Team members